Regencell Bioscience (RGC) had the highest return between January 2, 2025 and April 7, 2025 by a US stock with a market cap of $2B+, returning 469.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 1/2/2025 - 4/7/2025 | 469.84% |
Alignment Healthcare LLC (ALHC) | 1/2/2025 - 4/7/2025 | 57.42% |
DRDGOLD Limited ADR (DRD) | 1/2/2025 - 4/7/2025 | 56.62% |
Soleno Therapeutics (SLNO) | 1/2/2025 - 4/7/2025 | 55.45% |
TMC the metals (TMC) | 1/2/2025 - 4/7/2025 | 54.39% |
Harmony Gold Mining (HMY) | 1/2/2025 - 4/7/2025 | 53.92% |
Xpeng (XPEV) | 1/2/2025 - 4/7/2025 | 53.33% |
MP Materials (MP) | 1/2/2025 - 4/7/2025 | 51.36% |
IHS (IHS) | 1/2/2025 - 4/7/2025 | 50.68% |
Gold Fields Ltd ADR (GFI) | 1/2/2025 - 4/7/2025 | 50.51% |
Corcept Therapeutics (CORT) | 1/2/2025 - 4/7/2025 | 47.47% |
Orla Mining (ORLA) | 1/2/2025 - 4/7/2025 | 46.44% |
AngloGold Ashanti (AU) | 1/2/2025 - 4/7/2025 | 43.7% |
Grupo Cibest (CIB) | 1/2/2025 - 4/7/2025 | 43.36% |
CVS Health (CVS) | 1/2/2025 - 4/7/2025 | 43.34% |
Option Care Health (OPCH) | 1/2/2025 - 4/7/2025 | 41.07% |
Elbit Systems (ESLT) | 1/2/2025 - 4/7/2025 | 38.91% |
Compass (COMP) | 1/2/2025 - 4/7/2025 | 37.12% |
Rocket Companies (RKT) | 1/2/2025 - 4/7/2025 | 36.73% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 1/2/2025 - 4/7/2025 | 36.41% |
VNET Group Inc DRC (VNET) | 1/2/2025 - 4/7/2025 | 35.29% |
GRAIL, LLC (GRAL) | 1/2/2025 - 4/7/2025 | 34.54% |
Guardant Health (GH) | 1/2/2025 - 4/7/2025 | 33.7% |
Celsius (CELH) | 1/2/2025 - 4/7/2025 | 33.21% |
Mr Cooper (COOP) | 1/2/2025 - 4/7/2025 | 33.14% |
